Crossmark

Spontaneous breathing trials should be adapted for each patient according to the critical illness. A new individualised approach: the GLOBAL WEAN study

Crossref DOI link: https://doi.org/10.1007/s00134-024-07657-4

Published Online: 2024-10-25

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Capdevila, Mathieu

Aarab, Yassir

Monet, Clement

De Jong, Audrey https://orcid.org/0000-0002-3413-2752
Vonarb, Aurelie

Carr, Julie

Molinari, Nicolas

Capdevila, Xavier

Brochard, Laurent

Jaber, Samir
Funding

Funding for this research was provided by:

Centre Hospitalier Régional Universitaire de Montpellier

sfar
License Information

Text and Data Mining valid from 2024-10-25

Version of Record valid from 2024-10-25
More Information

Article History

Received: 23 July 2024

Accepted: 11 September 2024

First Online: 25 October 2024

Declarations

:

: ADJ reports receiving consulting fees from Drager, Medtronic and Fisher & Paykel. LB’s lab has received research grants from Medtronic, Drager and Stimit and equipment from Sentec, Fisher & Paykel and Philips and lecture fees from Fisher & Paykel. SJ reports receiving consulting fees from Drager, Mindray, Medtronic, Baxter, Fresenius-Xenios and Fisher & Paykel. No potential conflict of interest relevant to this article was reported for other authors.

: Informed consent was obtained from all individual participants included in the study or from legal guardians.

: The authors and participant has consented to the submission in the journal.

Document is current

Any future updates will be listed below